Skip to main content
SpringerLink
Log in

Kommentar zu: Immundiagnostik und -therapie des habituellen Aborts

Comments on: Immunodiagnostics and immunotherapy of habitual abortion

  • Blick zurück
  • Published:
Der Gynäkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. ESHRE Early Pregnancy Guideline Development Group (2017) ESHRE Guideline on the management of recurrent pregnancy loss, S 1–154

    Google Scholar 

  2. ACOG (2002) ACOG practice bulletin. Management of recurrent pregnancy loss. Number 24, February 2001. (Replaces Technical Bulletin Number 212, September 1995). American College of Obstetricians and Gynecologists. Int J Gynecol Obstet 78:179–190

    Article  Google Scholar 

  3. Bouteiller P, Rodriguez A‑M, Mallet V et al (2011) Placental expression of HLA class I genes. Am J Reprod Immunol 35:216–225

    Article  Google Scholar 

  4. Dahl M, Hviid TVF (2012) Human leucocyte antigen class Ib molecules in pregnancy success and early pregnancy loss. Hum Reprod Update 18:92–109

    Article  CAS  PubMed  Google Scholar 

  5. Fernandez N, Cooper J, Sprinks M et al (1999) A critical review of the role of the major histocompatibility complex in fertilization, preimplantation development and feto-maternal interactions. Hum Reprod Update 5:234–248

    Article  CAS  PubMed  Google Scholar 

  6. Guideline no 17 London RCOG G‑T (2011) The Investigation and Treatment of Couples with Recurrent First-trimester and Second-trimester Miscarriage. April 2011

  7. Hammer A, Hutter H, Blaschitz A et al (2011) Amnion epithelial cells, in contrast to trophoblast cells, express all classical HLA class I molecules together with HLA-G. Am J Reprod Immunol 37:161–171

    Article  Google Scholar 

  8. Hviid MM, Macklon N (2017) Immune modulation treatments-where is the evidence? Fertil Steril 107:1284–1293

    Article  PubMed  Google Scholar 

  9. Kuon RJ, Vomstein K, Weber M et al (2017) The „killer cell story“ in recurrent miscarriage: association between activated peripheral lymphocytes and uterine natural killer cells. J Reprod Immunol 119:9–14

    Article  CAS  PubMed  Google Scholar 

  10. Laird SM (2003) A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 9:163–174

    Article  CAS  PubMed  Google Scholar 

  11. Middleton D, Curran M, Maxwell L (2002) Natural killer cells and their receptors. Transpl Immunol 10:147–164

    Article  CAS  PubMed  Google Scholar 

  12. Miyakis S, Lockshin MD, Atsumi T et al (2006) International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 4:295–306

    Article  CAS  PubMed  Google Scholar 

  13. Seshadri S, Sunkara SK (2014) Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update 20:429–438

    Article  PubMed  Google Scholar 

  14. Thielens A, Vivier E, Romagné F (2012) NK cell MHC class I specific receptors (KIR): from biology to clinical intervention. Curr Opin Immunol 24:239–245

    Article  CAS  PubMed  Google Scholar 

  15. Toth B, Würfel W, Bohlmann MK et al (2015) Recurrent miscarriage: diagnostic and therapeutic procedures. Guideline of the DGGG (S1-level, AWMF registry no. 015/050, december 2013). Geburtshilfe Frauenheilkd 75:1117–1129

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Wilson WA, Gharavi AE, Koike T et al (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an International workshop. Arthritis Rheum 42:1309–1311

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für Gynäkologische Endokrinologie und Fertilitätsstörungen, Im Neuenheimer Feld 440, 69120, Heidelberg, Deutschland

    Ruben-J. Kuon

Authors
  1. Ruben-J. Kuon
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ruben-J. Kuon.

Ethics declarations

Interessenkonflikt

R.-J. Kuon gibt an, dass kein Interessenkonflikt besteht.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuon, RJ. Kommentar zu: Immundiagnostik und -therapie des habituellen Aborts. Gynäkologe 51, 326–328 (2018). https://doi.org/10.1007/s00129-018-4218-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00129-018-4218-4

Search

Navigation